SciELO - Scientific Electronic Library Online

 
vol.9 issue2Rapidly progressive glomerulonephritis secondary to pauciinmune vasculitis, a rare entity: case report and review of the literaturaHyperkalemia associated with the administration of trimethoprim sulfamethoxazole author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Revista Colombiana de Nefrología

On-line version ISSN 2500-5006

Abstract

NAKAMURA, Kenyi Kuratomi; MEJIA, Andrés Felipe; VALDERRAMA COMETA, Luis Alfonso  and  CASANOVA VALDERRAMA, María Eugenia. Atypical renal involvement in light chain amyloidosis: case report. Rev. colom. nefrol. [online]. 2022, vol.9, n.2, 403.  Epub Aug 01, 2022. ISSN 2500-5006.  https://doi.org/10.22265/acnef.9.2.559.

Introduction

Light chain amyloidosis is an entity triggered by the proliferation of a clone of plasma cells that generates the accumulation of light chains, which are deposited in the form of amyloid fibrils generating organic dysfunction. Renal compromise generally manifests as nephrotic syndrome, with a slow and progressive decline of renal function that can lead to dialysis therapy.

Purpose

The objective of this case report is to demonstrate the aggressive and subacute renal involvement of systemic amyloidosis.

Case presentation

We present a case of a 35-year-old male patient who consulted for general malaise, blurred vision, dizziness and oliguria with elevated nitrogen levels that progressed fastly to the requirement of hemodialysis in approximately 3 months. It was also reveal peripheral polyneuropathy, cardiac infiltration, and slight elevation of transaminases. Given the negativity of extension studies, amyloid deposits were documented histopathologically with positive immunofluorescence for LA. He is currently receiving chemotherapy regimen with adequate clinical stability and tolerance.

Conclusion and discussion

To conclude, AL amyloidosis is a rare entity, with significant multi-organ involvement and high rates of morbidity and mortality. In this case, the subacute involvement with an early requirement for dialysis therapy is emphasized, and the importance of suspicion and timely diagnosis in patients with kidney involvement and other systemic manifestations is emphasized.

Keywords : light chain amyloidosis; immunofluorescence; kidney disease; dialysis therapy..

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )